A Maryland biotechnology company is pushing for the state to expand eligibility to a pool of money from tobacco companies that funds anti-smoking and health programs.
20/20 Gene Systems Inc., a Rockville-based company, is requesting that $2 million in grants be made available for research into new screening and treatment methods that could lower mortality rates due to cancer. The money would come from the state’s Cigarette Restitution Fund.